Vamotinib
Cat.No:IV1650 Solarbio
CAS:1416241-23-0
Molecular Formula:C29H27F3N6O
Molecular Weight:532.56
Storage:Powder:2-8℃,2 years;Insolvent(mother liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to light yellow Solid
Qty:
Size:
{{cart_num}}
My CartCAS:1416241-23-0
Molecular Formula:C29H27F3N6O
Molecular Weight:532.56
Storage:Powder:2-8℃,2 years;Insolvent(mother liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Off-white to light yellow Solid
Qty:
Size:
| CAS | 1416241-23-0 |
| Name | Vamotinib |
| Molecular Formula | C29H27F3N6O |
| Molecular Weight | 532.56 |
| Solubility | Soluble in DMSO ≥5mg/mL |
| Purity | ≥98% |
| Appearance | Off-white to light yellow Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(mother liquid):-20℃,6 months;-80℃,1 year |
| Target Point | Bcr-Abl |
| Passage | Protein Tyrosine Kinase/RTK |
| Background | Vamotinib is a potent, selective tyrosine kinase inhibitor with oral activity. Vamotinib inhibits the autophosphorylation of BCR/ABL and BCR/ABL-T315I. Vamotinib shows anti-proliferative and anti-tumor activity. Vamotinib has potential in the study of drug-resistant Philadelphia chromosome-positive (Ph+) leukemia. |
| Unit | Bottle |
| Specification | 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download